126 related articles for article (PubMed ID: 1715731)
1. The value of immunohistochemistry in the differential diagnosis of endometrial carcinomas.
Dallenbach-Hellweg G; Lang-Avérous G; Hahn U
APMIS Suppl; 1991; 23():91-9. PubMed ID: 1715731
[TBL] [Abstract][Full Text] [Related]
2. [New cytogenetic classification of precancerous lesions and carcinomas of the endometrium: possibilities and limits of immunohistochemical differentiation].
Dallenbach-Hellweg G
Verh Dtsch Ges Pathol; 1991; 75():357-62. PubMed ID: 1724841
[TBL] [Abstract][Full Text] [Related]
3. [Primary squamous cell carcinomas of the endometrium. Clinico-pathologic data and histogenetic classification].
Horn LC; Bilek K
Zentralbl Pathol; 1993 Nov; 139(4-5):355-60. PubMed ID: 7510514
[TBL] [Abstract][Full Text] [Related]
4. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
5. Histopathology of functional and neoplastic changes in cervix and endometrium.
Dallenbach-Hellweg G
Verh Dtsch Ges Pathol; 1997; 81():240-4. PubMed ID: 9474876
[TBL] [Abstract][Full Text] [Related]
6. Mammaglobin expression in the female genital tract: immunohistochemical analysis in benign and neoplastic endocervix and endometrium.
Onuma K; Dabbs DJ; Bhargava R
Int J Gynecol Pathol; 2008 Jul; 27(3):418-25. PubMed ID: 18580321
[TBL] [Abstract][Full Text] [Related]
7. A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas.
McCluggage WG; Sumathi VP; McBride HA; Patterson A
Int J Gynecol Pathol; 2002 Jan; 21(1):11-5. PubMed ID: 11781517
[TBL] [Abstract][Full Text] [Related]
8. Squamous differentiation in carcinoma of the endometrium: a critical appraisal of adenoacanthoma and adenosquamous carcinoma.
Zaino RJ; Kurman RJ
Semin Diagn Pathol; 1988 May; 5(2):154-71. PubMed ID: 3041509
[TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemical investigation of vimentin of uterine endometrial and endocervical adenocarcinoma].
Ohwada M; Suzuki M; Tamada T
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Sep; 42(9):1237-43. PubMed ID: 2212824
[TBL] [Abstract][Full Text] [Related]
10. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
[TBL] [Abstract][Full Text] [Related]
11. [Adenocarcinoma of the cervix uteri (immunohistochemistry, ultrastructure, differential diagnosis from adenocarcinoma of the adjacent organs].
Petrov SV; Raĭkhlin NT; Serre G; Smedts F
Arkh Patol; 1995; 57(5):47-53. PubMed ID: 8579496
[TBL] [Abstract][Full Text] [Related]
12. Intermediate filaments in endometrial and endocervical carcinomas. The diagnostic utility of vimentin patterns.
Dabbs DJ; Geisinger KR; Norris HT
Am J Surg Pathol; 1986 Aug; 10(8):568-76. PubMed ID: 2426982
[TBL] [Abstract][Full Text] [Related]
13. p16 expression in the female genital tract and its value in diagnosis.
O'Neill CJ; McCluggage WG
Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
[TBL] [Abstract][Full Text] [Related]
14. p16 immunoreactivity may assist in the distinction between endometrial and endocervical adenocarcinoma.
McCluggage WG; Jenkins D
Int J Gynecol Pathol; 2003 Jul; 22(3):231-5. PubMed ID: 12819388
[TBL] [Abstract][Full Text] [Related]
15. Cervicovaginal cytology in uterine adenocarcinoma and adenosquamous carcinoma. Comparison of cytologic and histologic findings.
Costa MJ; Kenny MB; Naib ZM
Acta Cytol; 1991; 35(1):127-34. PubMed ID: 1994621
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical studies on carcinoembryonic antigen in adenocarcinomas of the uterus.
Ueda S; Tsubura A; Izumi H; Sasaki M; Morii S
Acta Pathol Jpn; 1983 Jan; 33(1):59-69. PubMed ID: 6340419
[TBL] [Abstract][Full Text] [Related]
17. Distinction between endocervical and endometrial adenocarcinoma with immunoperoxidase staining of carcinoembryonic antigen in routine histological tissue specimens.
Wahlström T; Lindgren J; Korhonen M; Seppälä M
Lancet; 1979 Dec; 2(8153):1159-60. PubMed ID: 91890
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis and the expression of Bcl-2 and Bax in patients with endometrioid, clear cell, and serous carcinomas of the uterine endometrium.
Kokawa K; Shikone T; Otani T; Nishiyama R; Ishii Y; Yagi S; Yamoto M
Gynecol Oncol; 2001 May; 81(2):178-83. PubMed ID: 11330946
[TBL] [Abstract][Full Text] [Related]
19. The significance of the pathologic findings in endometrial cancer.
Christopherson WM
Clin Obstet Gynaecol; 1986 Dec; 13(4):673-93. PubMed ID: 3024898
[TBL] [Abstract][Full Text] [Related]
20. True cytokeratin 8/18 immunohistochemistry is of no use in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.
Hsu JD; Yao CC; Lee MY; Kok LF; Wang PH; Tyan YS; Han CP
Int J Gynecol Pathol; 2010 May; 29(3):282-9. PubMed ID: 20407331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
